Sava Technologies raises £14m to commercialise wearable device

Sava raises $19M to advance glucose biosensor

This pain-free CGM that streamlines molecular insights. [Image from the Sava Technologies website]Sava Technologies announced today that it raised $19 million in a Series A financing round to support its wearable biosensor technology. Balderton Capital and Pentland Ventures led the round, with new investors Norrsken VC and JamJar Investments joining, too. Other investors included True, Italian Founders Fund, Athletico Ventures, SOLO Investments …

Sava Technologies raises £14m to commercialise wearable device

London-based startup Sava Technologies has raised £14.2m in Series A funding following promising early results from its pre-pivotal clinical trial.  The MedTech is developing real-time molecular health monitoring and will use the investment to accelerate regulatory approval and commercialisation of its wearable device. Founded in 2019 by Imperial College London bioengineers Renato Circi and Rafaël Michali, the company’s mission is to build the t…